GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calliditas Therapeutics AB (OSTO:CALTX) » Definitions » Other Current Liabilities

Calliditas Therapeutics AB (OSTO:CALTX) Other Current Liabilities : kr31 Mil (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Calliditas Therapeutics AB Other Current Liabilities?

Calliditas Therapeutics AB's other current liabilities for the quarter that ended in Dec. 2023 was kr31 Mil.

Calliditas Therapeutics AB's quarterly other current liabilities declined from Jun. 2023 (kr31 Mil) to Sep. 2023 (kr26 Mil) but then increased from Sep. 2023 (kr26 Mil) to Dec. 2023 (kr31 Mil).

Calliditas Therapeutics AB's annual other current liabilities increased from Dec. 2021 (kr19 Mil) to Dec. 2022 (kr31 Mil) and increased from Dec. 2022 (kr31 Mil) to Dec. 2023 (kr31 Mil).


Calliditas Therapeutics AB Other Current Liabilities Historical Data

The historical data trend for Calliditas Therapeutics AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calliditas Therapeutics AB Other Current Liabilities Chart

Calliditas Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only - - - - -

Calliditas Therapeutics AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Calliditas Therapeutics AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Calliditas Therapeutics AB Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Calliditas Therapeutics AB's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Calliditas Therapeutics AB (OSTO:CALTX) Business Description

Traded in Other Exchanges
Address
Kungsbron 1, D5, Stockholm, SWE, SE-111 22
Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with unmet medical needs. The company's pipeline candidate is TARPEYO medication to reduce proteinuria in IgA nephropathy.

Calliditas Therapeutics AB (OSTO:CALTX) Headlines

No Headlines